Behavioral Pathology

The UNC Endocrinology Diabetes Obesity Clinical Research Unit (ENDO CRU) is a leading site for clinical and translational studies of diabetes, obesity and its complications. We are well positioned to help apply diabetes treatments to cognitive disorders and recruit patients with diabetes and obesity to AD translational studies.

The Coleman lab studies how modifiable risk factors for AD promote its cellular and behavioral pathology. By using mouse models and human tissue, we attempt to identify novel diagnostic and therapeutic targets for AD. Studies focus on underlying cellular and molecular pathology that promote AD pathogenesis and progression